baber/WOPTO huggingface dataset:
Patent JP-H10198575-A (JP)
Title: Semiconductor device and its analyzing device
Inventor: GOTO SHINICHI
IPC: H01L21/822
Filed: 1997-01-07
Abstract: PROBLEM TO BE SOLVED: To safely and easily attain the exact analysis of a semiconductor device in an actual use state. SOLUTION: A semiconductor device 30 is attached on a mounting substrate 100 on which an electronic equipment 102 is loaded, and a CPU 6 executes the program of an ROM 2 in a normal operation. An analyzing device 40 is connected through switches 29a-29d with terminals 11-14 of the semiconductor device 30 and a terminal 104 of the electronic equipment 102, and when the signal value of the terminal 13 or the like is measured by a measuring part 26, and operational abnormality is detected, a switching signal is transmitted by an ROM execution area controlling part 22. Thus, an ROM execution area switching part 4 switches the ROM, and the CPU 6 executes the program for data transfer of an ROM 3. As a result, inside data are transferred to the analyzing device 40, and the inside state of the semiconductor device 30 is displayed on a displaying means 23.  Afterwards, the analyzing device 40 initializes the semiconductor device 30 or the like by an initializing part 27, and releases electrical connection with the semiconductor device 30 or the like by a connection controlling part 28.
Patent JP-S57114551-A (JP)
Title: Preparation of formic acid ester
Inventor: FURUSAKI SHINICHI
IPC: C07C69/06
Filed: 1981-01-08
Abstract: PURPOSE: To prepare the titled compound essentially free from by-products, separable and purifiable easily from the reaction mixture, and useful as a solvent, perfume, etc., with simple operation, by the catalytic vapor-phase reaction of H 2 , CO and a nitrous acid ester in the presence of a platinum-group metal and its salt.  
     CONSTITUTION: A formic acid ester is prepared, according to the reaction formula (R is alkyl or cycloalkyl), by the catalytic vapor-phase reaction of hydrogen, CO and a nitrous acid ester in the presence of a platinum-group metal (e.g. pref. Pd, Pt, Ru, etc. supported by a carrier such as activated carbon, alumina, silica, etc.) and its salt (e.g. nitrate, sulfate, phosphate, etc.). The amount of hydrogen is pref. 0.05W10mol, esp. 0.07W5mol, and that of CO is pref. 0.1W 100mol, esp. 0.2W50mol per 1 mol of the nitrous acid ester. The reaction is carried out at ≥40°C, usually 80W200°C, under 0.1W100atm, pref. atmospheric pressure W about 20atm. 
     COPYRIGHT: (C)1982,JPO&Japio
Patent JP-S5593053-A (JP)
Title: Ambient state detector using metal oxide semiconductor
Inventor: HIJIKATA MASAHARU
IPC: G01N27/12
Filed: 1979-01-05
Abstract: PURPOSE: To make it possible to detect two ambient states of combustion gas by connecting in series a nonlinear resistance element or circuit and a detecting element of a metal oxide semiconductor and then by leading two kinds of voltages out from two junction points.  
     CONSTITUTION: Over flames of a gas burner, etc., detecting element 1 is arranged which consists chiefly of a metal oxide semiconductor such as TiO 2 ; and resistance 2 is connected in series to the power side of detecting element 1, and a non-linear resistance element or circuit 3 is also connected in series to its earth side. This circuit 3 shows constant-resistance characteristics until an applied across voltage reaches a certain value, and then shows constant-voltage characteristics. This series circuit is applied with a constant voltage and two kinds of voltages are led out from power- side output terminal B and earth-side output terminal at junction points among the three. Consequently, two states, perfect combustion and non-combustion of gas, can be detected accurately. 
     COPYRIGHT: (C)1980,JPO&Japio
Patent JP-H04235431-A (JP)
Title: Data processing system
Inventor: SHINOHARA YOSHIYUKI
IPC: H04L12/40
Filed: 1991-01-09
Abstract: PURPOSE:To immediately use an office processor and to facilitate the use in the early morning or holiday especially by turning on the power supply of the office processor to synchronize with the turning-on the power supply of a workstation. CONSTITUTION:An automatic power supply controller 4 turning on the power supply of an office processor 1 when specific data is received while the power supply of the office processor is not turned on is connected to a cluster type data processing system composed of the office processor 1 and plural workstations 2 which are connected to a local area network 3. When the power supply is turned on to start a desired workstation 2, the specific data is transmitted to the controller 4. Receiving the specic data, the controller 4 turns on the power supply for the office processor 1, when it is not turned on.
Patent JP-H01177101-A (JP)
Title: Selecting device for redundant input signal
Inventor: OHASHI KOZO
IPC: G06F11/18
Filed: 1988-01-06
Abstract: PURPOSE:To realize a second-high system by using a dictionary to completely described a pattern of the input signal and at the same time recognizing the pattern through a comparing part. CONSTITUTION:The relation between the difference between a range R of the input signals and the signal contiguous to each input signal and a control limit epsilon43 is described at a dictionary part 42 together with the relation between the signal that is selected as the second-high one and the signal to be excluded. A sort part 41 processes the input pattern of the input signal to facilitate the reference to the part 42. A comparing part 44 decides a specific category of the part 42 that includes the combination of the input signals. A selection part 45 chooses an input channel changing candidate of channel control part 20. A change permitting part 46 changes the part 20 with an instruction of the part 45 only in case the necessity of a change is approved in terms of the limit epsilon43, etc. Thus it is possible to alternatively select a redundant input signal through the second-high system for the same measurement object.
Patent LT-IP462-A (LT)
Title: Hepatitis b virus surface proteins with reduced host carbohydrate content
Inventor: KNISKERN PETER J
IPC: C07K1/22
Filed: 1993-03-30
Abstract: In order to produce hepatitis B virus (HBV) surface proteins in the form of particles with substantially reduced entrapped carbohydrate content, DNA encoding the HBV surface proteins was expressed in a recombinant yeast host which is deficient in its ability to glycosylate proteins. These HBV surface proteins display the antigenic sites genetically encoded by the S domain of the HBV virion envelope open reading frame and contains substantially reduced levels of entrapped carbohydrate when compared with HBsAg particles produced in "wild-type" yeast cells. These particles are useful as a vaccine for both the active and passive treatment or prevention of disease and/or infection caused by HBV or other agents serologically related to HBV. <IMAGE>
Patent MA-40202-A (MA)
Title: Antibodies directed against cd127
Inventor: MARY CAROLINE
IPC: A61K39/00
Filed: 2015-06-10
Abstract: The invention relates to antibodies directed against cd127, the alpha chain of the interleukin 7 (il-7) receptor il-7r), and which have antagonist properties for il-7-il-7r interaction, may present cytotoxic activity against cd127 positive cells but do not increase the maturation of dendritic cells (dcs) induced by tslp, a cytokine also using cd127 as part of its receptor. Alternatively, or in addition, these antibodies do not induce the internalization of cd127 and/or inhibit the il7-induced internalization of cd127. According to another aspect of the invention antibodies are provided which recognize a human cd127 epitope comprising sequences from the 2b site of cd127, in particular the epitope comprising comprises the human cd127 sequences of domain d1 and of the 2b site of cd127, in particular the epitope comprises at least one sequence from d1 comprising seq id no: 115 (in particular comprising seq id no: 10) and/or seq id no: 111 and / or a sequence from the 2b site comprising the sequence of seq id no: 116 and optionally also comprises seq id no: 117 (in particular comprises seq id no: 111).The antibodies of the invention are suitable for use inorder to remedy to a condition diagnosed in a human patient which results from pathogenesis related to lymphopoiesis, when il-7 signalling pathways provide contribution to said pathogenesis, especially when an increase in the maturation, more precisely the upregulation of costimulatory molecules, of dendritic cells is undesirable.
Patent OA-10719-A (OA)
Title: System with satellites on equatorial and inclined orbits relaying information through intersatlliteslink and earth relays
Inventor: STUART JAMES R
IPC: H04B7/195
Filed: 1996-05-14
Abstract: A satellite system is disclosed. One embodiment of the invention utilizes both a single equatorial orbit plane (14) in combination with other satellites (12) moving in polar or inclined orbits (60, 63, 210). Although the preferred embodiments utilize a specific range of low Earth orbit altitudes, the satellites (12) are designed to fly in any orbit that is not a geosynchronous orbit. The satellites (12) are also capable of speeding packetized messages (225) around the globe either by working in combination with relay stations (34, 61, 65) on the ground, by transferring message payloads (225) across different orbits via the relay stations (34, 61, 65) or by conveying packetized payloads (225) through the use of inter-satellite links (55). The present invention will provide a wide range of non-voice, non-geostationary mobile satellite services to millions of subscribers around the globe.
Patent OA-10528-A (OA)
Title: A novel protein and process for preparing the same
Inventor: MAKISHIMA FUSAO
IPC: C12N1/21
Filed: 1997-10-17
Abstract: A protein having amino acid sequence in SEQ ID No.:1 of the Sequence Listing derived from human MP52, and a dimer protein thereof. A homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid sequence in SEQ ID No.:1 of the Sequence Listing with a methionine at the N-terminus, introducing the plasmid into E. coli for transformation, solubilizing inclusion bodies obtained by culturing the transformant, purifying the monomer protein from the solubilized solution, refolding the monomer protein into a dimer protein and purifying the same. The homodimer protein described above is useful as a pharmaceutical composition for treating cartilage and bone diseases.
Patent PH-20628-A (PH)
Title: Controlled absorption pharmaceutical formulation
Inventor: PANOZ DONALD EUGENE
IPC: A61K31/195
Filed: 1984-12-21
Abstract: A controlled absorption methyldopa formulation for oral administration comprises a pellet having a core of methyldopa or a pharmaceutically acceptable salt thereof in association with an organic acid, and an outer membrane which permits release of methyldopa in an aqueous medium at a controlled rate which is substantially pH independent. The pellet has a dissolution rate in vitro, which when measured in a Basket Assembly according to U.S. Pharmacopoeia XX at 37 DEG  C. and 75 r.p.m., is not more than 50% of the total methyldopa after one hour of measurement. Not more than 80% of the total methyldopa is released after a total of 3 hours of measurement and 100% release is achieved after a total of 7 hours.
Patent PH-23800-A (PH)
Title: Method and apparatus for making electrophotographic devices
Inventor: FOURNIER EUGENE
IPC: G03G5/082
Filed: 1985-02-05
Abstract: There are disclosed a method and apparatus (20, 110, 130) for depositing a layer of material onto the outer surfaces of a plurality of cylindrical members (12). The cylindrical members (12) are arranged to form a substantially closed loop with the longitudinal axes thereof disposed substantially parallel and the outer surfaces of adjacent members being closely spaced apart to form an inner chamber (32) which is substantially closed. Adjacent cylindrical members form narrow passages (66) which communicate with the inner chamber (32). At least one reaction gas is introduced into the inner chamber (32) through at least one of the narrow passages (52) and a plasma is formed from the at least one reaction gas within the inner chamber (32) to deposit the layer of material onto the outer surfaces of the cylindrical members (12). The plasma can be formed by using either microwave energy or radio frequency energy. More particularly disclosed is a method and apparatus for making electrophotographic drums.
Patent PH-24503-A (PH)
Title: New pharmaceutical compositions having psychotropic activity
Inventor: HARTOG JAN
IPC: C07D311/22
Filed: 1985-12-19
Abstract: The invention relates to new compositions with pyschotropic activity which comprise a compound of formula 1 as the active substance. The compounds of formula 1 are for the greater part new compounds. The invention therefore also relates to these new compounds and to the preparation thereof in a manner known for the synthesis of analogous compounds. <CHEM> l
Patent PH-25898-A (PH)
Title: Oral compositions
Inventor: BIRD NIGEL PETER
IPC: A61K31/375
Filed: 1988-12-13
Abstract: The disclosure concerns a toothpaste having antimicrobial activity packaged in a closed container comprising water, an ascorbic acid compound consisting of ascorbic acid, an ascorbic acid salt or an ascorbic acid ester and a copper catalyst for the auto-oxidation of the ascorbic acid compound during use of the toothpaste.
Patent PH-27014-A (PH)
Title: Compounds for the treatment of urinary incontinence
Inventor: SJOGREN CHRISTER
IPC: C07D207/06
Filed: 1989-11-03
Abstract: The invention concerns compounds having the formula I <CHEM> wherein Ar is a phenyl or benzyl group which is optionally substituted with hydroxy or alkoxy;  R<1> is hydrogen, lower alkyl, lower alkoxy, hydroxy;  R<2> is hydrogen, lower alkyl;  R<3> is NR<4>R<5>, wherein R<4> and R<5> which can be the same or different, are lower alkyl, or wherein R<4> and R<5>, when taken together, form a ring with the nitrogen atom, whereby said ring optionally is substituted with lower alkyl;  n is 0 or 1;  m is 2 or 3 and their salts with physiologically acceptable acids and when the compounds can be in form of optical isomers, the racemic mixture and the individual isomers, for the treatment of disorders of the urinary bladder.
Patent PH-27464-A (PH)
Title: 2,4,8-Trisubstituted-3H-6H-1,4-5A,8A-Tetraazaacenaphthylene-3,5-(4H)-diones and "?$,8-Trisubstituted-4,5-Dihydro-5-Thioxo-3H,6H-1,4,5A,8A-Tetraazacenaphthylene-3-ones
Inventor: TSENG SHIN SHYONG
IPC: A61K31/519
Filed: 1991-02-19
Abstract: Compounds of formula <CHEM> wherein R1 is hydrogen, alkyl, carboxamidomethyl, 4-chlorophenyl, benzyl and (4-nitrophenyl)-methyl; R2 and R3 are hydrogen or alkyl, R4 is 3-pyridinyl or <CHEM> where R6 and R7 are hydrogen, halogen, alkyl, alkoxy, N-alkyl-N-acylamino, nitro, and trifluoromethyl and where halogen is selected from chlorine, fluorine, bromine and iodine; R5 is hydrogen or alkyl; and A-B is -C=C-R3- or <CHEM> which are useful antihypertensive and anxiolytic agents. c
Patent UY-33045-A (UY)
Title: Evento de maiz transgenico mon 87427 y la escala de desarrollo relativo
Inventor: FENG PAUL C C
IPC: A23L7/10
Filed: 2010-11-22
Abstract: La invención presenta nucleótidos específicos para el evento transgénico de maíz MON 87427 y plantas, células vegetales, semillas, partes de plantas y productos de consumo que comprenden nucleótidos específicos para el evento transgénico de maíz MON 87427. La invención presenta además una Escala de  Desarrollo Relativo útil para monitorear y determinar el desarrollo reproductivo en el maíz que reconcilia las diferencias de desarrollo entre diversas variedades de maíz.
Patent UY-33196-A (UY)
Title: Antidotos de anticoagulantes
Inventor: RYN JOANNE VAN
IPC: A61K39/395
Filed: 2011-01-20
Abstract: La presente invención se refiere a moléculas de anticuerpo capaz de neutralizar la actividad de un anticoagulante y su uso en la terapia de efectos secundarios de una terapia anticoagulante. En particular dicha molécula de anticuerpo tiene especificidad de unión por el anticoagulante, o el anticoagulante es un heterociclo bicíclico disustituido de fórmula general (I): Ra - A - Het - B - Ar - E, o se selecciona de: dabigatrán, argatrobán, melagatrán, ximelagatrán, hirudina, bivalirudina, lepirudina, desirudina, apixabán, otamixabán, edoxabán, rivaroxabán, defibrotida, ramatrobán, antitrombina III, o drotrecogina alfa.
Patent UY-33546-A (UY)
Title: Corticosteroides para el tratamiento del dolor de las articulaciones
Inventor: NEIL BODIK
IPC: A61K9/14
Filed: 2011-08-03
Abstract: Se proporcionan formulaciones de micropartículas de corticosteroides para el tratamiento del dolor, incluido el dolor causado por enfermedades inflamatorias como, por ejemplo, osteoartritis y artritis reumatoidea, y para enlentecer, detener o revertir el daño tisular estructural causado por enfermedades inflamatorias, por ejemplo daños a los tejidos articulares o peri articular causados por osteoartritis o artritis reumatoidea. Las formulaciones de microparticulas de corticosteroides se administran localmente como una forma de dosificación de liberación sostenida (con o sin un componente de liberación inmediata) que resulta en eficacia acompañada de efectos clínicamente insignificantes o no mensurables sobre la producción de cortisol.
Patent UY-36067-A (UY)
Title: Góndola de una instalación de energía eólica
Inventor: WILKO GUDEWER
IPC: F16M13/00
Filed: 2015-04-07
Abstract: La invención se refiere a una góndola (1) de una instalación de energía eólica (100), en donde la instalación de energía eólica (100) presenta un generador para generar energía eléctrica a partir del viento, y la góndola (1) abarca: un soporte de máquina (10) para soportar el generador sobre una torre; un módulo portante (640) para alojar equipamientos de control eléctricos; y un revestimiento de góndola (1270) para proteger el módulo portante (640) y el soporte de máquina (10) contra influencias meteorológicas, en donde el módulo portante (640) y/o el revestimiento de góndola (1270) están vinculados mediante medios de desacoplamiento (634) con el soporte de máquina (10), de manera tal que de esta manera existe una vinculación elásticamente  amortiguada con el soporte de máquina (10).
Patent UY-37495-A (UY)
Title: Dinucleótidos cíclicos como agonistas de sting
Inventor: LU TIANBAO
IPC: C07H21/00
Filed: 2017-11-24
Abstract: Se describen compuestos, composiciones y métodos para tratar infecciones virales, enfermedades, síndromes o trastornos afectados por la modulación de STING. Tales compuestos se representan por la Fórmula (I) a continuación: en donde R1A, R1B, R1c, B1, R2A y R2B se definen en la presente descripción.
Patent UY-38759-A (UY)
Title: Tienilhidroxiisoxazolinas y derivados de las mismas
Inventor: PHILIPPE DESBORDES
IPC: A01N43/84
Filed: 2020-06-22
Abstract: La presente divulgación se refiere al uso de las tienilhidroxiisoxazolinas y sus derivados como fungicidas. También se refiere a nuevos derivados de tienilhidroxiisoxazolina, al uso de éstos como fungicidas y a las composiciones que los comprenden.
Patent UY-38783-A (UY)
Title: Compuestos de ciclohexanodiona herbicida
Inventor: HENNESSY ALAN JOSEPH
IPC: A01N43/54
Filed: 2020-07-14
Abstract: La presente invención se refiere a compuestos de Fórmula (I), donde R1, R2, R3,W, Y, Z y G con tal como se definen en el presente documento. La invención también se refiere a composiciones herbicidas que comprenden un compuesto de Fórmula (I) y a su uso para controlar malezas, en particular en cultivos de plantas útiles.
Patent UY-39345-A (UY)
Title: Proteínas que comprenden dominios de unión al antígeno hla-g y sus usos
Inventor: SINGH SANJAYA
IPC: C12P21/08
Filed: 2021-07-29
Abstract: La invención proporciona dominios de unión al antígeno que se unen a la proteína del antígeno leucocitario humano G (HLA-G) que comprende los dominios de unión al antígeno que se unen a HLA-G, polinucleótidos que los codifican, vectores, células huésped, métodos para elaborarlos y usarlos
Patent YU-17092-A (YU)
Inventor: COE J W
IPC: C07D491/04
Filed: 1992-02-19
Abstract: 2,4-diaminoquinazoline derivatives as potentiators of chemotherapeutic agents in the treatment of cancer.
Patent YU-31392-A (YU)
Inventor: VALLALOBOS A
IPC: C07D211/08
Filed: 1992-03-27
Abstract: Compounds of formula (I) wherein R<1>, R<2>, R<7>, R<8>, X, Y, M and L are defined as below. The compounds of formula (I) are cholinesterase inhibitors and are useful in enhancing memory in patients suffering from dementia and Alzheimer's disease.
Patent YU-35491-A (YU)
Inventor: SATO A
IPC: C07D498/06
Filed: 1991-02-28
Abstract: A process for selectively producing an (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3 dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hemihydrate or monohydrate, which comprises controlling the water content of an aqueous solvent in which an (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl )-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid is dissolved during a crystallization.
Patent YU-46992-A (YU)
Title: Uredjaj za merenje struje, napona i faznog ugla izmedju njih i odredjivanje redosleda faza
Inventor: KOROLIJA M
Filed: 1992-05-05
Abstract: uredjaj za merenje struje, napona, ugla izmedju njih i redosleda faza prema pronalasku bazira se na tome što se struja meri obuhvatnim strujnim kleštima (2) čiji je sekundar vezan na strujno-naponski pretvarač (3), pri čemu klešta i pretvarač čine elektronski kompen-zovan strujni transformator sa nultim fluksom. Izlaz pretvarača (3) vezan je na detektor (5) za odredjivanje prolaska struje kroz nulu, kao i na preklopnik (8) za prebacivanje merene veličine na instrument (9). Naponi svake faze odvedeni su na reduktore (4) za svodjenje na vrednost pogodnu za elektronsku obradu, a zatim na detektore (6) za odredjivanje prolaska kroz nulu. Izlazi detektora (5) i detektora (6) faze R vezani su na blok (7) za merenje ugla, čiji je izlaz odveden na preklopnik 8 zajedno sa izlazima sva tri naponska reduktora. Izlazi naponskih detektora (6) sve tri fazo vezani su na blok (10) za odredjivanje redosleda faza. Uredjaj se najbolje može iskorisiti za merenje struje, napona, ugla izmedju njih i redosleda faza u elektroenergetskim i industrijskim objektima visokog napona u kojima se električne veličine mere posredno preko mernih transfor-matora.
Patent YU-73090-A (YU)
Title: Držač za endotrahealnu cev
Inventor: PIWONKA P
IPC: A61M16/04
Filed: 1990-04-13
Abstract: Pronalazak se odnosi na držač za endotrahealnu cev, koja se sastoji trake 12 za držanje koja može da se pričvrsti na cev, koja je sa krajevima odvojivo pričvršćena na glavi pacijenta. Da bi se omogućilo tačno i sigurno postavljanje cevi, a da za ovo nije potrebno pričvršćivanje na površinu kože pacijenta, ima predloženi držač bar čeonu traku 14 i bar zateznu traku 15 koja ide preko glave, koja je sa ovom čvrsto spojena, na čijim su krajevima krajevi trake za držanje 12 odvojivo pričvršćeni.
Patent YU-2400-A (YU)
Title: Production procedure for ploymer bituminous paste
Inventor: SRECKO STEFANOVIC
Filed: 2000-01-20
Abstract: Production procedure for polymer bituminous paste has the aim to obtain paste that can be used in civil engineering as hidroinsulation against damp and water, and, at the same time, it can be used as anticorosive means for the protection of waterpipes and gaspipes as well as cable systems. Apart from that, it is also suitable for the protection of car body from salt. It has also been shown that it is good protection from UV radiation. produced on the base of bitumen that is polimerized with modified copolymer of silicone. It has high water resistance, it is safe at the temperatures of -20 C to 100 C. At the high temperatures of 120 C, it does not leak, at the temperatures of under O C, it does not crack and it is not deformed on the thing or object whereon applied.